Former Vertex executive to spearhead the clinical development of Absci’s expanding AI-designed therapeutics pipeline ...

Former Vertex executive to spearhead the clinical development of Absci's expanding AI-designed therapeutics pipeline Chief Innovation Officer Andreas Busch to retire March 31, 2026 and will continue ...

“President Trump on Thursday announced he was erasing the scientific finding that climate change endangers human health and the environment, ending the federal government’s legal authority to control ...

The Trump Administration’s extraordinary and politically motivated demand for information on nearly all federal funding going to 14 states and Washington, D.C. — all of which voted against the ...

The Trump administration pushed out two officials focused on neutralizing technological threats from China, people familiar with the matter said, in the latest dismissals of key personnel working on ...

An immigration court in San Francisco is the latest to close its doors, NPR has learned, as the Trump administration seeks to remake the system that offers immigrants due process. In 2025, the Trump ...

The Trump administration will appeal a federal judge’s ruling that declared the rescission of $2.6 billion in federal funds from Harvard University was unconstitutional. U.S. District Judge Allison ...

Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...

The Trump administration is intensifying its efforts to restrict legal migration, pausing all asylum decisions after an Afghan national was charged in the attack on two National Guard members. The ...

Target RWE, a leader in advancing modern evidence generation for complex clinical and regulatory challenges, today announced the presentation of compelling new findings from the REPATHA-CE study of ...

Every 40 seconds, someone in the U.S. has a heart attack or stroke, and in most cases, it’s their first. 1 The good news? The risk for these devastating events can actually be significantly reduced by ...

Amgen Chairman, President and CEO Bob Bradway joins 'Mad Money' host Jim Cramer to talk quarterly results, its recent drug trials, what is ahead for the company and more. Got a confidential news tip?